File:Elsevier_logo_2019.svg · Wikimedia Commons · See Wikimedia Commons
Elsevier
Sign in to saveAlso known as elsevier.com, Elsevier B.V., Elsevier Publishing Company, Elsevier BV, Elsevier Health Sciences
Elsevier ( ) is a Dutch academic publishing company specializing in scientific, technical, and medical content. Its products include journals such as The Lancet, Cell, the ScienceDirect collection of electronic journals, Trends, the Current Opinion series, the online citation database Scopus, the SciVal tool for measuring research performance, the ClinicalKey search engine for clinicians, and the ClinicalPath evidence-based cancer care service. Elsevier's products and services include digital tools for data management, instruction, research analytics, and assessment. Elsevier is part of the RE
Key facts
- Company.name
- Elsevier
- Company.logo
- Elsevier logo 2019.svg
- Company.type
- Subsidiary
- Company.industry
- Publishing
- Company.location_city
- Amsterdam, Netherlands
- Company.key_people
- Kumsal Bayazit, Chief Executive Officer
- Company.revenue
- £2.909 billion (2022)
- Company.operating_income
- £1.078 billion (2022)
- Company.net_income
- £2.021 billion (2022)
- Company.num_employees
- 9500
- Company.parent
- RELX
via Wikipedia infobox
Wikidata facts
- Employees
- 9500
- Revenue
- 3062000000
- Official website
- www.elsevier.com
Show 7 more facts
- inception
- 1993-00-00
- social media followers
- 21100
- net profit
- 600000000
- Commons category
- Elsevier
- privacy policy URL
- www.elsevier.com/legal/privacy-policy
- terms of service URL
- www.elsevier.com/legal/elsevier-website-terms-and-conditions
- operating income
- 1165000000
Sources (15)
via Wikidata · CC0
~45 min read
Article
50 sectionsContents
- History
- Company statistics
- Market model
- Products and services
- Pricing
- Mergers and acquisitions
- Conferences
- Shill review offer
- Blocking text mining research
- Fossil fuel company consulting and advocacy
- Relationship with academic institutions
- Finland
- France
- Germany
- Hungary
- Iran
- Italy
- Netherlands
- Norway
- South Korea
- Sweden
- Taiwan
- United States
- Ukraine
- Criticism and controversies
- Restrictive access practices
- Lobbying efforts against open access
- Sale of open-access articles
- Action against academics posting their own articles online
- Lawsuits against paper-sharing sites
- Resignation of editorial boards
- "The Cost of Knowledge" boycott
- Plan S open-access initiative
- Business practices and editorial standards
- "Who's Afraid of Peer Review"
- Fake journals
- ''Chaos, Solitons & Fractals''
- Plagiarism
- Scientific racism
- Manipulation of bibliometrics
- Climate change
- Involvement in international arms trade
- Antitrust lawsuit
- Awards
- Imprints
- See also
- References
- Citations
- Sources
- External links
Elsevier ( ) is a Dutch academic publishing company specializing in scientific, technical, and medical content. Its products include journals such as The Lancet, Cell, the ScienceDirect collection of electronic journals, Trends, the Current Opinion series, the online citation database Scopus, the SciVal tool for measuring research performance, the ClinicalKey search engine for clinicians, and the ClinicalPath evidence-based cancer care service. Elsevier's products and services include digital tools for data management, instruction, research analytics, and assessment. Elsevier is part of the RELX Group, known until 2015 as Reed Elsevier, a publicly traded company. According to RELX reports, in 2022 Elsevier published more than 600,000 articles annually in over 2,800 journals. As of 2018, its archives contained over 17 million documents and 40,000 e-books, with over one billion annual downloads.
Researchers have criticized Elsevier for its high profit margins and copyright practices. The company had a reported profit before tax of £2.295 billion with an adjusted operating margin of 33.1% in 2023. Much of the research that Elsevier publishes is publicly funded; its high costs have led to accusations of rent-seeking, boycotts against the company, and the rise of alternate avenues for academic publication and access, such as preprint servers and shadow libraries.